Artivion, Inc. (AORT)
22.60
-0.16
(-0.70%)
USD |
NYSE |
May 28, 16:00
22.60
0.00 (0.00%)
After-Hours: 19:11
Artivion Research and Development Expense (Annual) : 30.99M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| NeuroOne Medical Technologies Corp. | 4.983M |
| Edwards Lifesciences Corp. | 1.079B |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| PetVivo Holdings, Inc. | 1.583M |
| INVO Fertility, Inc. | -- |